News

Elon Musk has said that he used ketamine as a treatment in the past, but he denied reports that he was taking it frequently ...
While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s ...
Tens of millions of people with depression aren't properly diagnosed. Stanford researchers show that brain imaging could revolutionize treatment. Researchers at Stanford recently described six ...
Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that tran ...
A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...
Relief Mental Health, an award-winning outpatient provider of innovative mental health services, proudly announces the ...
Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...
Intravenous ketamine and intranasal esketamine may reduce emergency department visits for suicide in patients with treatment resistant depression.
Objective Ketamine and esketamine have both shown significant antidepressant effects in treatment-resistant depression (TRD) and conflicting evidence suggests that dissociation induced by these drugs ...
Overall heterogeneity varied from 5.7% to 87.6% Our findings suggested that effect sizes for depression severity, as well as response and remission rates, were numerically greater for racemic ketamine ...